Gyre Therapeutics (GYRE) Interest Coverage Ratio (QoQ) (2010 - 2020)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 88.46% |
| Dec 31, 2014 | -82.95% |
| Sep 30, 2014 | 11.06% |
| Jun 30, 2014 | -77.94% |
| Mar 31, 2014 | 84.45% |
| Dec 31, 2013 | -31.60% |
| Sep 30, 2013 | -13.37% |
| Jun 30, 2013 | -72.49% |
| Mar 31, 2013 | 42.75% |
| Dec 31, 2012 | -123.10% |
| Sep 30, 2012 | -162.58% |
| Jun 30, 2012 | 747.03% |
| Mar 31, 2012 | 124.85% |
| Dec 31, 2011 | -28.49% |
| Sep 30, 2011 | -169.87% |
| Jun 30, 2011 | -122.34% |
| Mar 31, 2011 | 1,240.51% |
| Dec 31, 2010 | -148.95% |
| Sep 30, 2010 | -45.60% |